, Tracking Stock Market Picks
Enter Symbol:

up 384.57 %

MEDIVATION INC (MDVN) rated Buy with price target $125 by Brean Murray

Posted on: Tuesday,  Sep 4, 2012  9:25 AM ET by Brean Murray

Brean Murray rated Buy MEDIVATION INC (NASDAQ: MDVN) on 09/04/2012. Previously Brean Murray rated Buy MEDIVATION INC (NASDAQ: MDVN) on 11/03/2011.,
when the stock price was $19.00. Since then, MEDIVATION INC has gained 384.58% as of 01/27/2016's recent price of $92.07.
If you would have followed the previous Brean Murray's recommendation on MDVN, you would have gained 384.57% of your investment in 1546 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/4/2012 9:25 AM Buy
54.50 62.50
as of 12/31/2012
1 Week up  2.25 %
1 Month down  -1.89 %
3 Months down  -9.21 %
1 YTD up  121.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/3/2011 2:25 PM Buy
19.00 38.50
8/10/2010 9:25 AM Sell
4.74 3.00
9/3/2008 11:25 AM Sell
15.18 5.50
11/7/2007 9:25 AM Sell
10.32 2.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy